Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vella

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|June 1, 1996
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequenciesH Jacobsen, M Hänggi, M Ott, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatmentL Sarmati, L Ercoli, S G Parisi, et al.
Journal of Medical Virology|January 4, 1998
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (Invirase) treatmentL Sarmati, E Nicastri, G el-Sawaf, et al.
Recenti Progressi in Medicina|April 11, 2001
[Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?]F S Vella, P Orlando, F Attanasi, et al.
AIDS (London, England)|June 1, 1996
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study GroupA Carr, S Vella, M D de Jong, et al.
AIDS (London, England)|November 5, 1999
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoringG Gatti, A Di Biagio, R Casazza, et al.
AIDS (London, England)|January 1, 1995
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patientsS Vella, M Giuliano, M Floridia, et al.
AIDS (London, England)|April 15, 1999
Thymus volume correlates with the progression of vertical HIV infectionA Vigano', S Vella, N Principi, et al.
HIV Medicine|May 16, 2002
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trialM Floridia, V Fragola, C M Galluzzo, et al.
Antiviral Research|January 1, 1996
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivityS Vella, C Galluzzo, G Giannini, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|June 1, 1996
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequenciesH Jacobsen, M Hänggi, M Ott, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatmentL Sarmati, L Ercoli, S G Parisi, et al.
Journal of Medical Virology|January 4, 1998
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (Invirase) treatmentL Sarmati, E Nicastri, G el-Sawaf, et al.
Recenti Progressi in Medicina|April 11, 2001
[Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?]F S Vella, P Orlando, F Attanasi, et al.
AIDS (London, England)|June 1, 1996
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study GroupA Carr, S Vella, M D de Jong, et al.
AIDS (London, England)|November 5, 1999
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoringG Gatti, A Di Biagio, R Casazza, et al.
AIDS (London, England)|January 1, 1995
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patientsS Vella, M Giuliano, M Floridia, et al.
AIDS (London, England)|April 15, 1999
Thymus volume correlates with the progression of vertical HIV infectionA Vigano', S Vella, N Principi, et al.
HIV Medicine|May 16, 2002
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trialM Floridia, V Fragola, C M Galluzzo, et al.
Antiviral Research|January 1, 1996
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivityS Vella, C Galluzzo, G Giannini, et al.
Pageof 18